EBMT will be actively participating in the 68th ASH Annual Meeting & Exposition, taking place December 12-15, 2026, in New Orleans, Louisiana, USA.
EBMT representatives will present 56 communications across various oral and poster sessions. Below, you will find the list of presentations. You can click on each title to view the full abstract and presentation details on the ASH website.
Congratulations to all co-authors and thank you for your continued support!
Oral Abstract Session
Saturday, December 12
Myeloablative haploidentical bone marrow transplantation with post-transplant Cyclophosphamide is comparable to myeloablative standard matched unrelated peripheral blood stem cell transplantation for acute myeloid leukemia: An EBMT-ALWP matched-pair analysis
9:30 AM – 9:45 AM
MCCNO - 388-390
Post-transplant cyclophosphamide versus ATG-based gvhd prophylaxis after fludarabine-melphalan-based conditioning for acute myeloid leukemia in complete remission: An EBMT acute leukemia working party registry analysis of 2,259 patients.
10:30 AM – 10:45 AM
MCCNO - 388-390
Feasibility and outcomes of first-line autologous stem cell transplantation in 167 elderly patients (≥70 years) with primary central cervous system lymphoma: A multi-center registry analysis from the EBMT lymphoma working party
10:30 AM – 10:45 AM
MCCNO - 271-273
Recipient age remains the major predictor of outcome after 10/10 matched unrelated donor transplantation for severe aplastic anemia in adults: An EBMT saawp analysis
10:45 AM – 11:00 AM
MCCNO - 295-296
Haplo-identical donor versus young unrelated mismatched donor for elderly patients with acute myeloid leukemia transplanted in first remission: A study from the acute leukemia working party of the EBMT
10:45 AM – 11:00 AM
MCCNO - 388-390
Real-world outcomes of CAR T-cell therapy versus allogeneic hematopoietic cell transplantation in relapsed and refractory mantle cell lymphoma: A retrospective study of the lymphoma working party of the EBMT
2:00 PM – 2:15 PM
MCCNO - New Orleans Theatre A
Defining the optimal peripheral blood graft cell dose for haploidentical transplantation with PTCy in AML: A study from the acute leukemia working party of the EBMT
4:00 PM – 4:15 PM
MCCNO - 391-392
Five-year outcomes of the EBMT-saawp race study investigating anti-thymocyte globuline and cyclosporine with or without eltrombopag as front-line therapy for severe aplastic anemia
4:15 PM – 4:30 PM
MCCNO - 295-296
Improved outcomes of hematopoietic cell transplantation in down syndrome acute myeloid leukemia (DS-AML) in the modern era: A combined CIBMTR/EBMT analysis
4:45 PM – 5:00 PM
MCCNO - 278-282
Assessing the impact of donor age and single HLA mismatch in children with ALL and AML in complete remission receiving an unrelated HCT: An EBMT PDWP study
5:00 PM – 5:15 PM
MCCNO - 278-282
Sunday, December 13
Lower GVHD without loss of disease control with αβTCR/CD19 depletion versus post-transplant cyclophosphamide in adults with hematological malignancies: A retrospective study of the cellular therapy and immunobiology working party (CTIWP) of the EBMT
9:45 AM – 10:00 AM
MCCNO - 388-390
Non-relapse mortality after allogeneic hematopoietic cell transplantation in patients aged 70 years and older: A study of 5,469 patients from the complications working party of the EBMT
4:30 PM – 4:45 PM
MCCNO - 388-390
Comparable outcomes following haploidentical, MSD, and MUD HCT in adult AML patients with pre-transplant detectable MRD using PTCy-based GVHD prophylaxis: A study from the ALWP of the EBMT
5:45 PM – 6:00 PM
MCCNO - Great Hall AD
Monday, December 14
Low-dose total body irradiation (2 Gy) does not reduce post-transplant fertility in young females with severe aplastic anemia: A saawp-EBMT study
3:00 PM – 3:15 PM
MCCNO - 353-355
Improving survival by consolidation with second allogeneic transplantation for relapsed AML in CR2
5:30 PM – 5:45 PM
MCCNO - Great Hall BC
Post-transplant cyclophosphamide or standard graft-versus-host disease prophylaxis for T-cell lymphoma patients undergoing allogeneic hematopoietic cell transplantation: A registry study from the EBMT lymphoma working party
5:00 PM – 5:15 PM
MCCNO - 353-355
Poster Abstract Session
Saturday, December 12
5:30 PM – 7:30 PM
MCCNO - Hall F
Sunday, December 13
6:00 PM – 8:00 PM
MCCNO - Hall F
Monday, December 14
6:00 PM – 8:00 PM
MCCNO - Hall F